Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FY204
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $181,790
Award facts
- Contract value 100% obligated
- $181,789.73 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $181,789.73 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, with an ultimate completion date of January 20, 2026. This delivery order, issued without set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal military and veteran healthcare systems. The company's work is performed at its corporate office location in Conshohocken, PA.
This delivery order falls within Amerisourcebergen Drug Corp's broader mission to supply comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The parent organization, Cencora, Inc. (doing business as Amerisourcebergen), holds the master indefinite delivery contract with DLA and maintains significant pharmaceutical distribution capabilities. The Defense Logistics Agency's Medical Supply Chain relies on such delivery orders to fulfill essential medication and medical commodity requirements for treatment facilities and healthcare systems serving active-duty personnel, veterans, and other federal beneficiaries. As the child entity under Cencora, Inc., Amerisourcebergen Drug Corp continues to demonstrate its capability to meet federal procurement standards through open competitive procedures and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DU26FY204?
SPE2DU26FY204 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DU26FY204 worth?
The government has obligated $181,790 on SPE2DU26FY204.
Is contract SPE2DU26FY204 an order under another contract?
Yes. SPE2DU26FY204 is a delivery order under SPE2DU25D4115, an indefinite delivery contract.
Was contract SPE2DU26FY204 competed?
The extent of competition for SPE2DU26FY204 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award